Literature DB >> 9878706

Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship.

M Balestrino1, R Rebaudo, G Lunardi.   

Abstract

Incubation of hippocampal slices with different concentrations of creatine (0.5, 1, 10, 25 mM) results in a dose-dependent increase in intracellular phosphocreatine (PCr). Electrophysiological evidence suggests that this effect can protect neurons from anoxic damage by delaying the depletion of ATP during oxygen deprivation. In this paper we show that incubation of brain slices with varying doses of creatine increases intracellular phosphocreatine and delays anoxic depolarization (AD) in a dose-dependent way. Specifically, addition to the incubation medium of 1 mM creatine significantly increased AD latency during hypoxia and prevented irreversible neuronal damage. Adding 0.5 mM creatine had no significant effect. Higher concentrations of creatine (up to 25 mM) did not provide any better protection. Our data also suggest a linear correlation between intracellular PCr and AD latency. These data report neural protection by exogenous creatine at concentrations lower than those usually reported in the literature. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878706     DOI: 10.1016/s0006-8993(98)01131-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation.

Authors:  B Wilken; J M Ramirez; I Probst; D W Richter; F Hanefeld
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Increase of cerebral phosphocreatine in normal rats after intracerebroventricular administration of creatine.

Authors:  R Rebaudo; R Melani; F Carità; L Rosi; V Picchio; P Ruggeri; N Izvarina; M Balestrino
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

3.  The neuroprotective effect of creatine in rats with cerebral ischemia.

Authors:  V A Otellin; D E Korzhevskii; V B Kostkin; M Balestrino; M V Lensman; S A Polenov
Journal:  Dokl Biol Sci       Date:  2003 May-Jun

4.  Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.

Authors:  Patrizia Garbati; Enrico Adriano; Annalisa Salis; Silvia Ravera; Gianluca Damonte; Enrico Millo; Maurizio Balestrino
Journal:  Neurochem Res       Date:  2013-11-12       Impact factor: 3.996

5.  A novel hypothesis about mechanisms affecting conduction velocity of central myelinated fibers.

Authors:  Enrico Adriano; Luisa Perasso; Isabella Panfoli; Silvia Ravera; Carlo Gandolfo; Gianluigi Mancardi; Alessandro Morelli; Maurizio Balestrino
Journal:  Neurochem Res       Date:  2011-05-08       Impact factor: 3.996

6.  Support of Nerve Conduction by Respiring Myelin Sheath: Role of Connexons.

Authors:  Silvia Ravera; Martina Bartolucci; Enrico Adriano; Patrizia Garbati; Sara Ferrando; Paola Ramoino; Daniela Calzia; Alessandro Morelli; Maurizio Balestrino; Isabella Panfoli
Journal:  Mol Neurobiol       Date:  2015-06-02       Impact factor: 5.590

7.  Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

Authors:  Clare E Turner; Winston D Byblow; Nicholas Gant
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

8.  NADH hyperoxidation correlates with enhanced susceptibility of aged rats to hypoxia.

Authors:  Kelley A Foster; Russell R Margraf; Dennis A Turner
Journal:  Neurobiol Aging       Date:  2006-12-20       Impact factor: 4.673

9.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

10.  Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury.

Authors:  Stephen W Scheff; Harabhajan S Dhillon
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.